pdCSM-cancer: Using Graph-Based Signatures to Identify Small Molecules with Anticancer Properties

[Image: see text] The development of new, effective, and safe drugs to treat cancer remains a challenging and time-consuming task due to limited hit rates, restraining subsequent development efforts. Despite the impressive progress of quantitative structure–activity relationship and machine learning...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Jarf, Raghad, de Sá, Alex G. C., Pires, Douglas E. V., Ascher, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317153/
https://www.ncbi.nlm.nih.gov/pubmed/34213323
http://dx.doi.org/10.1021/acs.jcim.1c00168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317153/
https://www.ncbi.nlm.nih.gov/pubmed/34213323
http://dx.doi.org/10.1021/acs.jcim.1c00168

Ejemplares similares